IDM Pharma Inc.’s (IDMI) Childhood Bone Tumor Treatment Gains Positive Review, Marketing Recommendation by European Medicines Agency
Osteosarcoma is a childhood cancer, usually affecting the bones of children and young adults during adolescent growth spurts. Most of the tumors are found in large bones such as the femur, tibia and humerus, though the tumors can occur in any bone. Although fewer than 1,000 new cases are diagnosed in the U.S. each year, the survival rate of children with osteosarcoma has remained at 60-65 percent since the 1980s. IDM Pharma Inc. (Nasdaq: IDMI) concentrates on developing innovative cancer products that destroy cancer cells by activating immunity or preventing tumor recurrence. The company focuses on reaching full therapeutic and…